Launching stakeholder discussions on identified regulatory needs for nanotechnology-enabled health products
The development of nanotechnology-enabled health products offers innovative therapeutic and diagnostic opportunities to address medical needs. At the moment, no specific regulatory framework exists for such products since they can be covered by the existing frameworks for medicinal products and medi...
Main Authors: | Blanka Halamoda-Kenzaoui, Helen Box, Merel van Elk, Sandra Gaitan, Robert E. Geertsma, Eusebio Gainza Lafuente, Andrew Owen, Angel del Pozo, Matthias Roesslein, Susanne Bremer-Hoffmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Andover House Inc.
|
Series: | Precision Nanomedicine |
Online Access: | http://prnano.scholasticahq.com/article/13521-launching-stakeholder-discussions-on-identified-regulatory-needs-for-nanotechnology-enabled-health-products.pdf |
Similar Items
-
Main trends of immune effects triggered by nanomedicines in preclinical studies
by: Halamoda-Kenzaoui B, et al.
Published: (2018-09-01) -
Tiered testing of micro- and nanoplastics using intestinal in vitro models to support hazard assessments
by: Gerrit Bredeck, et al.
Published: (2022-01-01) -
Enabling effective product launch decisions
by: Akamphon, Sappinandana
Published: (2009) -
Yeasts in Nanotechnology-Enabled Oral Vaccine and Gene Delivery
by: Elena Ivanova
Published: (2021-09-01) -
Nanotechnology-Enabled COVID-19 mRNA Vaccines
by: Yu Gao, et al.
Published: (2021-08-01)